229 related articles for article (PubMed ID: 35154137)
1. Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc
Song X; Zhang W; Zhai L; Guo J; Zhao Y; Zhang L; Hu L; Xiong X; Zhou D; Lv M; Yang W
Front Immunol; 2022; 13():819089. PubMed ID: 35154137
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
Huang J; Mikszta JA; Ferriter MS; Jiang G; Harvey NG; Dyas B; Roy CJ; Ulrich RG; Sullivan VJ
Hum Vaccin; 2007; 3(3):90-3. PubMed ID: 17375001
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
[TBL] [Abstract][Full Text] [Related]
6. A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.
Klas SD; Petrie CR; Warwood SJ; Williams MS; Olds CL; Stenz JP; Cheff AM; Hinchcliffe M; Richardson C; Wimer S
Vaccine; 2008 Oct; 26(43):5494-502. PubMed ID: 18703110
[TBL] [Abstract][Full Text] [Related]
7. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
8. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.
Chichester JA; Manceva SD; Rhee A; Coffin MV; Musiychuk K; Mett V; Shamloul M; Norikane J; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2013 Mar; 9(3):544-52. PubMed ID: 23324615
[TBL] [Abstract][Full Text] [Related]
9. Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.
Flick-Smith HC; Eyles JE; Hebdon R; Waters EL; Beedham RJ; Stagg TJ; Miller J; Alpar HO; Baillie LW; Williamson ED
Infect Immun; 2002 Apr; 70(4):2022-8. PubMed ID: 11895967
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
[TBL] [Abstract][Full Text] [Related]
11. Stability and pre-formulation development of a plant-produced anthrax vaccine candidate.
Jones RM; Burke M; Dubose D; Chichester JA; Manceva S; Horsey A; Streatfield SJ; Breit J; Yusibov V
Vaccine; 2017 Oct; 35(41):5463-5470. PubMed ID: 28117174
[TBL] [Abstract][Full Text] [Related]
12. Inhalable vaccine of bacterial culture supernatant extract mediates protection against fatal pulmonary anthrax.
Zhai LN; Zhao Y; Song XL; Qin TT; Zhang ZJ; Wang JZ; Sui CY; Zhang LL; Lv M; Hu LF; Zhou DS; Fang TY; Yang WH; Wang YC
Emerg Microbes Infect; 2023 Dec; 12(1):2191741. PubMed ID: 36920800
[TBL] [Abstract][Full Text] [Related]
13. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
[TBL] [Abstract][Full Text] [Related]
14. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
Kachura MA; Hickle C; Kell SA; Sathe A; Calacsan C; Kiwan R; Hall B; Milley R; Ott G; Coffman RL; Kanzler H; Campbell JD
J Immunol; 2016 Jan; 196(1):284-97. PubMed ID: 26608924
[TBL] [Abstract][Full Text] [Related]
15. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
Flick-Smith HC; Waters EL; Walker NJ; Miller J; Stagg AJ; Green M; Williamson ED
Microb Pathog; 2005 Jan; 38(1):33-40. PubMed ID: 15652293
[TBL] [Abstract][Full Text] [Related]
16. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
[TBL] [Abstract][Full Text] [Related]
17. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
18. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR
Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043
[TBL] [Abstract][Full Text] [Related]
19. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
